Russel J. Reiter Honored with Lifetime Achievement Award by Drug Research & Development Conference

The organizing committee of the Drug Research & Development Conference proudly announces that Russel J. Reiter, Distinguished Professor at the The University of Texas Health Science Center at San Antonio, has been awarded the Lifetime Achievement Award in recognition of his outstanding contributions to biomedical science and pharmaceutical research.

The award was presented during the Drug Research & Development Conference, held February 23–25, 2026, in San Diego, California. The event brought together leading scientists, clinicians, and industry experts from around the world to discuss the latest advancements in drug discovery and development.

Professor Reiter is internationally recognized for his pioneering research on melatonin biology, circadian rhythms, oxidative stress, and aging. Over several decades, his groundbreaking work has significantly advanced scientific understanding of how melatonin influences human health, disease prevention, and therapeutic innovation.

With more than a thousand scientific publications and an extraordinary global impact, Professor Reiter’s work continues to shape modern research in neuroendocrinology, antioxidant biology, and translational medicine. The Lifetime Achievement Award recognizes his decades of scientific leadership, groundbreaking discoveries, and lasting influence on biomedical research worldwide.

About the Drug Research & Development Conference:

The Drug Research & Development Conference brings together leading scientists, researchers, clinicians, and industry innovators to discuss the latest breakthroughs in pharmaceutical science, translational medicine, and therapeutic innovation. The conference serves as a global platform for collaboration, knowledge exchange, and the advancement of next-generation drug discovery and development.